American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$272M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$237M |
| 3 |
Kenvue
KVUE
|
+$236M |
| 4 |
Norfolk Southern
NSC
|
+$219M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$230M |
| 2 |
Walt Disney
DIS
|
+$193M |
| 3 |
Advanced Micro Devices
AMD
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
MarketAxess Holdings
MKTX
|
+$148M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2676
3D Systems Corporation
DDD
$287M
| $75.5K | ﹤0.01% |
15,382
+998
| +7% | +$4.9K |
|
2677
Luminar Technologies
LAZR
$121M
| $75.5K | ﹤0.01% |
1,106
+300
| +37% | +$20.5K |
|
2678
Aldeyra Therapeutics
ALDX
$331M
| $74.7K | ﹤0.01% |
11,178
-9,329
| -45% | -$62.3K |
|
|
ROVR
2679
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $72.4K | ﹤0.01% |
11,569
-20,013
| -63% | -$125K |
|
2680
Altice USA
ATUS
$1.12B
| $72.1K | ﹤0.01% |
22,052
+52
| +0.2% | +$170 |
|
|
FREE
2681
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $69K | ﹤0.01% |
+19,160
| New | +$69K |
|
2682
Tile Shop Holdings
TTSH
$279M
| $68.9K | ﹤0.01% |
12,549
+430
| +4% | +$2.36K |
|
|
NNDM
2683
Nano Dimension
NNDM
$313M
| $68.5K | ﹤0.01% |
+25,192
| New | +$68.5K |
|
2684
AXT Inc
AXTI
$157M
| $67.1K | ﹤0.01% |
27,958
+6,565
| +31% | +$15.8K |
|
2685
Carisma Therapeutics
CARM
$15.8M
| $66.8K | ﹤0.01% |
+15,781
| New | +$66.8K |
|
2686
Acacia Research
ACTG
$320M
| $66.6K | ﹤0.01% |
18,257
+1,301
| +8% | +$4.75K |
|
2687
Stoke Therapeutics
STOK
$1.33B
| $63.6K | ﹤0.01% |
+16,143
| New | +$63.6K |
|
2688
Rekor Systems
REKR
$149M
| $63.4K | ﹤0.01% |
+22,491
| New | +$63.4K |
|
2689
Kopin
KOPN
$360M
| $62.7K | ﹤0.01% |
+51,416
| New | +$62.7K |
|
2690
Mistras Group
MG
$305M
| $62.6K | ﹤0.01% |
+11,488
| New | +$62.6K |
|
2691
ATAI Life Sciences
ATAI
$1.01B
| $61.5K | ﹤0.01% |
47,663
+12,756
| +37% | +$16.5K |
|
2692
Hyliion Holdings
HYLN
$286M
| $61.1K | ﹤0.01% |
51,763
+1,153
| +2% | +$1.36K |
|
2693
Apyx Medical
APYX
$76M
| $61K | ﹤0.01% |
+19,068
| New | +$61K |
|
2694
Fossil Group
FOSL
$161M
| $60.5K | ﹤0.01% |
29,391
+7,680
| +35% | +$15.8K |
|
2695
CommScope
COMM
$3.62B
| $60.5K | ﹤0.01% |
18,005
+117
| +0.7% | +$393 |
|
2696
Verrica Pharmaceuticals
VRCA
$47M
| $59.3K | ﹤0.01% |
+1,528
| New | +$59.3K |
|
2697
C4 Therapeutics
CCCC
$191M
| $59.1K | ﹤0.01% |
31,796
+7,843
| +33% | +$14.6K |
|
2698
TrueCar
TRUE
$203M
| $57.7K | ﹤0.01% |
27,882
+225
| +0.8% | +$466 |
|
|
LL
2699
DELISTED
LL Flooring Holdings, Inc.
LL
| $57.7K | ﹤0.01% |
18,201
+5,036
| +38% | +$16K |
|
2700
Acumen Pharmaceuticals
ABOS
$83M
| $57.3K | ﹤0.01% |
+13,816
| New | +$57.3K |
|